General MedicationsINTRAVENOUSStandard
SUGAMMADEX SODIUM
SUGAMMADEX SODIUM
Standard Dose
EQ 500MG BASE/5ML (EQ 100MG BASE/ML)
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview SUGAMMADEX SODIUM is listed in Drugs@FDA under application 214337 (ANDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient SUGAMMADEX SODIUM Form and strength SOLUTION;INTRAVENOUS - EQ 500MG BASE/5ML (EQ 100MG BASE/ML) Sponsor ASPIRO Submission history Latest submission status date: 2024-10-08 00:00:00.
Structured Monograph
Clinical summary
Approval overview SUGAMMADEX SODIUM is listed in Drugs@FDA under application 214337 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient SUGAMMADEX SODIUM Form and strength SOLUTION;INTRAVENOUS - EQ 500MG BASE/5ML (EQ 100MG BASE/ML) Sponsor ASPIRO Submission history Latest submission status date: 2024-10-08 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.